Literature DB >> 8641967

Deletion mapping of chromosome 10 in human glioma.

Y Sonoda1, Y Murakami, T Tominaga, T Kayama, T Yoshimoto, T Sekiya.   

Abstract

We analyzed DNAs from 35 gliomas (27 malignant, grades III and IV; 8 less malignant, grades I and II) for loss of heterozygosity (LOH) using microsatellite sequences on chromosome 10 as polymorphic markers. An LOH was found in 8 of 11 (73%) glioblastomas (grade IV) and 4 of 16 (25%) grade III gliomas, but not in the less malignant types. We detected three commonly deleted regions. One was located in a telomeric region of 10p and the others were relatively large regions of 10q. Our results suggested that three putative tumor suppressor genes on chromosome 10 are involved in the malignant progression of gliomas.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8641967      PMCID： PMC5921111          DOI： 10.1111/j.1349-7006.1996.tb00231.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN： 0910-5050


  27 in total

1.  Allelotyping of human prostatic adenocarcinoma.

Authors:  K Kunimi; U S Bergerheim; I L Larsson; P Ekman; V P Collins
Journal:  Genomics       Date:  1991-11       Impact factor: 5.736

2.  Retinoblastoma gene deletions in human glioblastomas.

Authors:  D J Venter; K L Bevan; R L Ludwig; T E Riley; P S Jat; D G Thomas; M D Noble
Journal:  Oncogene       Date:  1991-03       Impact factor: 9.867

3.  Molecular analysis of deletions of the short arm of chromosome 9 in human gliomas.

Authors:  O I Olopade; R B Jenkins; D T Ransom; K Malik; H Pomykala; T Nobori; J M Cowan; J D Rowley; M O Diaz
Journal:  Cancer Res       Date:  1992-05-01       Impact factor: 12.701

4.  Mitotic recombination of chromosome 17 in astrocytomas.

Authors:  C D James; E Carlbom; M Nordenskjold; V P Collins; W K Cavenee
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

5.  Loss of heterozygosity on chromosome 10 in human glioblastoma multiforme.

Authors:  M Fujimoto; D W Fults; G A Thomas; Y Nakamura; M P Heilbrun; R White; J L Story; S L Naylor; K S Kagan-Hallet; P J Sheridan
Journal:  Genomics       Date:  1989-02       Impact factor: 5.736

6.  Abnormalities of chromosome 22 in human brain tumors determined by combined cytogenetic and molecular genetic approaches.

Authors:  J A Rey; M J Bello; J M de Campos; J Vaquero; M E Kusak; J L Sarasa; A Pestaña
Journal:  Cancer Genet Cytogenet       Date:  1993-03

7.  Correlation of cytogenetic analysis and loss of heterozygosity studies in human diffuse astrocytomas and mixed oligo-astrocytomas.

Authors:  D T Ransom; S R Ritland; C A Moertel; R J Dahl; J R O'Fallon; B W Scheithauer; D W Kimmel; P J Kelly; O I Olopade; M O Diaz
Journal:  Genes Chromosomes Cancer       Date:  1992-11       Impact factor: 5.006

Review 8.  Gene and chromosomal alterations associated with the development of human gliomas.

Authors:  V P Collins; C D James
Journal:  FASEB J       Date:  1993-07       Impact factor: 5.191

9.  Two tumor suppressive loci on chromosome 10 involved in human glioblastomas.

Authors:  P A Steck; A H Ligon; P Cheong; W K Yung; M A Pershouse
Journal:  Genes Chromosomes Cancer       Date:  1995-04       Impact factor: 5.006

10.  Loss of heterozygosity at 11p15 in malignant glioma.

Authors:  Y Sonoda; M Iizuka; J Yasuda; R Makino; T Ono; T Kayama; T Yoshimoto; T Sekiya
Journal:  Cancer Res       Date:  1995-05-15       Impact factor: 12.701
View more
  10 in total

1.  Acquisition of the glioblastoma phenotype during astrocytoma progression is associated with loss of heterozygosity on 10q25-qter.

Authors:  H Fujisawa; M Kurrer; R M Reis; Y Yonekawa; P Kleihues; H Ohgaki
Journal:  Am J Pathol       Date:  1999-08       Impact factor: 4.307

Review 2.  Molecular pathogenesis of astrocytic tumours.

Authors:  Koichi Ichimura; Hiroko Ohgaki; Paul Kleihues; V Peter Collins
Journal:  J Neurooncol       Date:  2004-11       Impact factor: 4.130

3.  Prognostic value of loss of heterozygosity around three candidate tumor suppressor genes on chromosome 10q in astrocytomas.

Authors:  Kinya Terada; Takashi Tamiya; Shigeru Daido; Hirokazu Kambara; Hiroaki Tanaka; Yasuhiro Ono; Kengo Matsumoto; Sachio Ito; Mamoru Ouchida; Takashi Ohmoto; Kenji Shimizu
Journal:  J Neurooncol       Date:  2002-06       Impact factor: 4.130

4.  In vitro loss of heterozygosity targets the PTEN/MMAC1 gene in melanoma.

Authors:  G P Robertson; F B Furnari; M E Miele; M J Glendening; D R Welch; J W Fountain; T G Lugo; H J Huang; W K Cavenee
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

5.  Mutation in the PTEN/MMAC1 gene in archival low grade and high grade gliomas.

Authors:  M P Davies; F E Gibbs; N Halliwell; K A Joyce; M M Roebuck; M L Rossi; J Salisbury; D R Sibson; L Tacconi; C Walker
Journal:  Br J Cancer       Date:  1999-03       Impact factor: 7.640

6.  Multiplexed analysis of post-PCR fluorescence-labeled microsatellite alleles and statistical evaluation of their imbalance in brain tumors.

Authors:  Koji Yoshimoto; Toru Iwaki; Takanori Inamura; Masashi Fukui; Tomoko Tahira; Kenshi Hayashi
Journal:  Jpn J Cancer Res       Date:  2002-03

7.  PTEN / MMAC1 mutation and frequent loss of heterozygosity identified in chromosome 10q in a subset of hepatocellular carcinomas.

Authors:  Y Fujiwara; D S Hoon; T Yamada; K Umeshita; M Gotoh; M Sakon; I Nishisho; M Monden
Journal:  Jpn J Cancer Res       Date:  2000-03

Review 8.  The Role of 2-Oxoglutarate Dependent Dioxygenases in Gliomas and Glioblastomas: A Review of Epigenetic Reprogramming and Hypoxic Response.

Authors:  Rebekah L I Crake; Eleanor R Burgess; Janice A Royds; Elisabeth Phillips; Margreet C M Vissers; Gabi U Dachs
Journal:  Front Oncol       Date:  2021-03-25       Impact factor: 6.244

9.  ADD3 Deletion in Glioblastoma Predicts Disease Status and Survival.

Authors:  Karrie Mei-Yee Kiang; Stella Sun; Gilberto Ka-Kit Leung
Journal:  Front Oncol       Date:  2021-12-14       Impact factor: 6.244

10.  The role of factor inhibiting HIF (FIH-1) in inhibiting HIF-1 transcriptional activity in glioblastoma multiforme.

Authors:  Enfeng Wang; Chunyang Zhang; Navatha Polavaram; Fengming Liu; Gang Wu; Mark A Schroeder; Julie S Lau; Debabrata Mukhopadhyay; Shi-Wen Jiang; Brian Patrick O'Neill; Kaustubh Datta; Jinping Li
Journal:  PLoS One       Date:  2014-01-23       Impact factor: 3.240
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.